Cargando…

Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer

BACKGROUND: The aim of this study was to examine the impact of the Charlson Comorbidity Index-Grade (CCI-G) on predicting outcomes and overall survival after open and minimally invasive esophagectomy (MIE). METHODS: One hundred and forty-six patients who underwent esophagectomy between 1995 and 2011...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolan, James P., Kaur, Taranjeet, Diggs, Brian S., Luna, Renato A., Schipper, Paul H., Tieu, Brandon H., Sheppard, Brett C., Hunter, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102391/
https://www.ncbi.nlm.nih.gov/pubmed/23846365
http://dx.doi.org/10.1007/s00464-013-3066-5
_version_ 1783511814043074560
author Dolan, James P.
Kaur, Taranjeet
Diggs, Brian S.
Luna, Renato A.
Schipper, Paul H.
Tieu, Brandon H.
Sheppard, Brett C.
Hunter, John G.
author_facet Dolan, James P.
Kaur, Taranjeet
Diggs, Brian S.
Luna, Renato A.
Schipper, Paul H.
Tieu, Brandon H.
Sheppard, Brett C.
Hunter, John G.
author_sort Dolan, James P.
collection PubMed
description BACKGROUND: The aim of this study was to examine the impact of the Charlson Comorbidity Index-Grade (CCI-G) on predicting outcomes and overall survival after open and minimally invasive esophagectomy (MIE). METHODS: One hundred and forty-six patients who underwent esophagectomy between 1995 and 2011 for stage II and III cancer were selected and separated into open esophagectomy (Open) and MIE groups. Risk adjustment was performed using the CCI-G. The outcomes of interest were operative time, estimated blood loss (EBL), lymph node harvest, length of hospital stay (LOS), major complications, 30-day mortality, and overall survival. RESULTS: Sixty-four patients (44 %) underwent Open while 71 (49 %) had MIE. An additional (7 %) were converted and classified with MIE. There was no significant difference between MIE and Open in terms of operative time. MIE had less EBL (mean difference = 234 mL, p < 0.001), higher lymph node harvest (mean = 7.4 nodes, p < 0.001), and shorter LOS (median = 1.5 days, p = 0.02). Atrial arrhythmias were the most frequent complication, occurring in 33 % of patients in both the MIE and the Open group (p = 0.988). Thirty-day mortality was 2 % for MIE and 5 % for Open (p = 0.459). Five-year survival was 41 % for MIE and 33 % for Open (p = 0.513). Operative approach, age, gender, BMI, clinical stage, and neoadjuvant therapy did not have any significant effect on the outcomes or overall survival. CCI-G influenced outcomes with operative time, LOS, cardiovascular complication, and anastomotic leak rate, favoring CCI-G 0 compared to CCI-G 3. Overall survival was worse for CCI-G 1 in comparison with CCI-G 0 [hazard ratio (HR) 1.99, p = 0.027]. CONCLUSIONS: MIE is a safe alternative to open esophagectomy for the treatment of locally advanced esophageal cancer. The presence of comorbidities increased operative time, length of hospital stay, and postoperative complications while worsening overall survival.
format Online
Article
Text
id pubmed-7102391
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-71023912020-03-31 Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer Dolan, James P. Kaur, Taranjeet Diggs, Brian S. Luna, Renato A. Schipper, Paul H. Tieu, Brandon H. Sheppard, Brett C. Hunter, John G. Surg Endosc Article BACKGROUND: The aim of this study was to examine the impact of the Charlson Comorbidity Index-Grade (CCI-G) on predicting outcomes and overall survival after open and minimally invasive esophagectomy (MIE). METHODS: One hundred and forty-six patients who underwent esophagectomy between 1995 and 2011 for stage II and III cancer were selected and separated into open esophagectomy (Open) and MIE groups. Risk adjustment was performed using the CCI-G. The outcomes of interest were operative time, estimated blood loss (EBL), lymph node harvest, length of hospital stay (LOS), major complications, 30-day mortality, and overall survival. RESULTS: Sixty-four patients (44 %) underwent Open while 71 (49 %) had MIE. An additional (7 %) were converted and classified with MIE. There was no significant difference between MIE and Open in terms of operative time. MIE had less EBL (mean difference = 234 mL, p < 0.001), higher lymph node harvest (mean = 7.4 nodes, p < 0.001), and shorter LOS (median = 1.5 days, p = 0.02). Atrial arrhythmias were the most frequent complication, occurring in 33 % of patients in both the MIE and the Open group (p = 0.988). Thirty-day mortality was 2 % for MIE and 5 % for Open (p = 0.459). Five-year survival was 41 % for MIE and 33 % for Open (p = 0.513). Operative approach, age, gender, BMI, clinical stage, and neoadjuvant therapy did not have any significant effect on the outcomes or overall survival. CCI-G influenced outcomes with operative time, LOS, cardiovascular complication, and anastomotic leak rate, favoring CCI-G 0 compared to CCI-G 3. Overall survival was worse for CCI-G 1 in comparison with CCI-G 0 [hazard ratio (HR) 1.99, p = 0.027]. CONCLUSIONS: MIE is a safe alternative to open esophagectomy for the treatment of locally advanced esophageal cancer. The presence of comorbidities increased operative time, length of hospital stay, and postoperative complications while worsening overall survival. Springer US 2013-07-12 2013 /pmc/articles/PMC7102391/ /pubmed/23846365 http://dx.doi.org/10.1007/s00464-013-3066-5 Text en © Springer Science+Business Media New York 2013 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Dolan, James P.
Kaur, Taranjeet
Diggs, Brian S.
Luna, Renato A.
Schipper, Paul H.
Tieu, Brandon H.
Sheppard, Brett C.
Hunter, John G.
Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
title Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
title_full Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
title_fullStr Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
title_full_unstemmed Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
title_short Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
title_sort impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102391/
https://www.ncbi.nlm.nih.gov/pubmed/23846365
http://dx.doi.org/10.1007/s00464-013-3066-5
work_keys_str_mv AT dolanjamesp impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer
AT kaurtaranjeet impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer
AT diggsbrians impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer
AT lunarenatoa impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer
AT schipperpaulh impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer
AT tieubrandonh impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer
AT sheppardbrettc impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer
AT hunterjohng impactofcomorbidityonoutcomesandoverallsurvivalafteropenandminimallyinvasiveesophagectomyforlocallyadvancedesophagealcancer